Dynamic42 interviewed by MDR

23. February 2021 In News

Dynamic42 interviewed by MDR

In the interview with MDR Thüringen, we answer many questions about our company, our vision and we reveal how we came up with the name “Dynamic42”. You can find the complete interview and the feature in the MDR Thüringen Journal here.

Press Release | Dynamic42 and EPO Close the Gap in Brain Cancer Research

Dynamic42 GmbH and EPO Experimental Pharmacology & Oncology are collaborating to advance brain cancer research by integrating organ-on-chip technologies into preclinical drug development.

Press Release | Setting a New Benchmark in Functional Barrier Analysis

Dynamic42 announces the launch of its DynamicOrgan® TEER-Sensor System enabling real-time, non-invasive monitoring of barrier integrity within an organ-on-chip model.